Flector and Levothyroxine sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flector (diclofenac epolamine) and Levothyroxine sodium (levothyroxine sodium). Common drug interactions include arthralgia among females and epilepsy among males.

The phase IV clinical study analyzes what interactions people have when they take Flector and Levothyroxine sodium. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Flector?

Flector has active ingredients of diclofenac epolamine. It is often used in pain. eHealthMe is studying from 5,112 Flector users. Check the latest studies of Flector.

What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 129,812 Levothyroxine sodium users. Check the latest studies of Levothyroxine sodium.

On Jul, 07, 2026

64 people who take Flector and Levothyroxine sodium together, and have interactions are studied.

Flector and Levothyroxine sodium drug interactions.

What are the common drug interactions of Flector and Levothyroxine Sodium, by gender? *:

female:

Arthralgia (joint pain)
Diarrhoea
Drug ineffective
Hyperkalaemia (damage to or disease of the kidney)
Renal failure (kidney dysfunction)
Dizziness
Dehydration (dryness resulting from the removal of water)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Pain in extremity
Tremor (trembling or shaking movements in one or more parts of your body)

male:

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Fatigue (feeling of tiredness)
Influenza like illness
Lethargy (tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Memory impairment
Urticaria (rash of round, red welts on the skin that itch intensely)
Pain in extremity
Peptic ulcer perforation

What are the common drug interactions of Flector and Levothyroxine Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Memory impairment
Drug ineffective

50-59:

Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Dyspnoea (difficult or laboured respiration)
Facial bones fracture (bone fracture of face)
Fall
Gastric ulcer (stomach ulcer)
Hyperkalaemia (damage to or disease of the kidney)
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
Infusion site erythema (reddening of the skin at infusion site)
Infusion site oedema (swelling from excessive accumulation of watery fluid from infusion site)
Joint swelling

60+:

Headache (pain in head)
Diarrhoea
Blood pressure fluctuation
Body height decreased
Constipation
Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
Hypoaesthesia (reduced sense of touch or sensation)
Injection site haemorrhage (bleeding from injection site)
Local swelling (swelling at the site of some application of substance or injury)
Mobility decreased (ability to move is reduced)

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 6 people, 9.38%
High Blood Cholesterol: 6 people, 9.38%
Joint Pain: 5 people, 7.81%
Immunodeficiency Common Variable: 5 people, 7.81%
Pain In Extremity: 4 people, 6.25%
Insomnia (sleeplessness): 4 people, 6.25%
Hypersensitivity: 4 people, 6.25%
High Blood Pressure: 4 people, 6.25%
Back Pain: 4 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Flector and Levothyroxine sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously